Article info

Download PDFPDF

Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
  1. Dr Carine Salliot, Hôpital Cochin, service de Rhumatologie B, 27 rue du faubourg Saint-Jacques, 75014 Paris, France; carinesalliot{at}wanadoo.fr
View Full Text

Citation

Salliot C, Dougados M, Gossec L
Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials

Publication history

  • Accepted January 6, 2008
  • First published January 18, 2008.
Online issue publication 
December 16, 2008

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.